BNP PARIBAS FINANCIAL MARKETS - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 145 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2014. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$585,147
+22.5%
15,322
+31.9%
0.00%0.0%
Q2 2023$477,602
-44.1%
11,612
-22.0%
0.00%0.0%
Q1 2023$855,007
-67.6%
14,893
-68.4%
0.00%
-75.0%
Q4 2022$2,639,495
-99.9%
47,075
+3.8%
0.00%0.0%
Q2 2022$2,449,612,000
-45.9%
45,338
-35.7%
0.00%
-33.3%
Q1 2022$4,528,466,000
-19.1%
70,471
-15.7%
0.01%
-25.0%
Q4 2021$5,599,426,000
+315.0%
83,586
+324.3%
0.01%
+300.0%
Q3 2021$1,349,124,000
+64.8%
19,701
+64.2%
0.00%
+100.0%
Q2 2021$818,812,000
+15.4%
11,999
+16.9%
0.00%0.0%
Q1 2021$709,347,000
+80.1%
10,267
+69.2%
0.00%0.0%
Q4 2020$393,870,000
-56.0%
6,067
+1.5%
0.00%0.0%
Q3 2020$894,677,000
-78.2%
5,978
-84.9%
0.00%
-85.7%
Q2 2020$4,094,991,000
+23.5%
39,626
-46.6%
0.01%0.0%
Q1 2020$3,314,871,000
+719.7%
74,208
+969.4%
0.01%
+600.0%
Q4 2019$404,405,000
-39.9%
6,939
-38.0%
0.00%0.0%
Q3 2019$672,664,000
+811.7%
11,198
+747.7%
0.00%
Q2 2019$73,778,000
-42.9%
1,321
-43.1%
0.00%
Q1 2019$129,270,000
+171.9%
2,320
+120.1%
0.00%
Q4 2018$47,535,000
-90.1%
1,054
-85.5%
0.00%
-100.0%
Q3 2018$479,073,000
+15.4%
7,273
+12.9%
0.00%0.0%
Q2 2018$415,058,000
-64.0%
6,444
-69.1%
0.00%
-50.0%
Q1 2018$1,154,060,000
-8.7%
20,854
-21.1%
0.00%0.0%
Q4 2017$1,264,365,000
-23.7%
26,418
-19.5%
0.00%
-50.0%
Q3 2017$1,657,107,000
-79.9%
32,827
-78.3%
0.00%
-84.0%
Q2 2017$8,229,974,000
+122.5%
150,981
+72.0%
0.02%
+150.0%
Q1 2017$3,698,214,000
+541.7%
87,781
+1206.7%
0.01%
+233.3%
Q4 2016$576,337,000
-95.8%
6,718
-96.0%
0.00%
-94.6%
Q3 2016$13,724,103,000
-4.7%
166,252
-7.9%
0.06%
-13.8%
Q2 2016$14,394,466,000
+3.6%
180,427
-12.5%
0.06%
+10.2%
Q1 2016$13,888,959,000
-39.5%
206,190
-39.1%
0.06%
+5.4%
Q4 2015$22,958,306,000
+97.6%
338,718
+73.6%
0.06%
+93.1%
Q3 2015$11,621,480,000
-19.8%
195,155
-9.3%
0.03%
-27.5%
Q2 2015$14,497,418,000
+11.1%
215,191
+1.7%
0.04%
+11.1%
Q1 2015$13,044,770,000
+42.7%
211,594
+25.5%
0.04%
+12.5%
Q4 2014$9,140,575,000
+28.2%
168,552
+17.3%
0.03%
+433.3%
Q3 2014$7,132,027,000
+49.4%
143,675
+41.7%
0.01%
+50.0%
Q2 2014$4,772,355,000
+10370.3%
101,410
+10041.0%
0.00%
Q1 2014$45,580,000
-26.1%
1,000
-22.6%
0.00%
Q4 2013$61,641,000
-79.9%
1,292
-83.1%
0.00%
Q3 2013$306,906,000
+19.3%
7,625
+8.6%
0.00%
Q2 2013$257,289,0007,0240.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q1 2014
NameSharesValueWeighting ↓
SECTOR GAMMA AS 386,966$21,415,0003.86%
Champlain Investment Partners, LLC 4,997,595$276,567,0002.99%
Broadfin Capital, LLC 298,424$16,515,0002.57%
FALCON POINT CAPITAL, LLC 218,264$12,079,0002.42%
Tributary Capital Management, LLC 388,264$21,487,0001.80%
Bellevue Group AG 191,000$10,570,0001.05%
FORTALEZA ASSET MANAGEMENT INC/ 2,305$128,0000.78%
SECTORAL ASSET MANAGEMENT INC 123,198$6,818,0000.75%
Mitsubishi UFJ Asset Management (UK) Ltd. 11,400$630,0000.42%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 544,007$30,105,0000.37%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders